Effectiveness of BNT162b2 vaccine to preventing COVID-19 in healthcare personnel

被引:4
作者
Chico-Sanchez, Pablo [1 ]
Gras-Valenti, Paula [1 ]
Algado-Selles, Natividad [1 ]
Merino-Lucas, Esperanza [2 ]
Carlos Rodriguez-Diaz, Juan [3 ]
Ronda-Perez, Elena [4 ,5 ]
Sanchez-Paya, Jose [1 ]
机构
[1] Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Serv Med Prevent, Unidad Epidemiol, Alicante, Spain
[2] Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Unidad Enfermedades Infecciosas, Alicante, Spain
[3] Hosp Gen Univ Alicante, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Serv Microbiol, Alicante, Spain
[4] Univ Alicante, Grp Invest Salud Publ, Alicante, Spain
[5] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
关键词
COVID-19; SARS-CoV-2; vaccines; Case-control studies; Immunogenicity vaccine; Health personnel;
D O I
10.1016/j.gaceta.2021.11.003
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To assess the effectiveness of the vaccine against SARS-CoV-2 (BNT162b2) in healthcare per-sonnel of a health department. Method: Test-negative case-control study. Healthcare personnel with suspected COVID-19 and health-care personnel close contacts of COVID-19 cases were included between January 27th and June 6 th, 2021. They were PCR tested for SARS-CoV-2; those with positive PCR were considered cases and those with negative PCR were considered controls. The adjusted vaccine effectiveness (aVE) to prevent COVID-19 cases and their 95% confidence interval (95%CI) were calculated using the formula VE = (1 - odds ratio) x 100.Results: 624 healthcare personnel were included, of which 43 (6.9%) were considered cases and 581 (93.8%) controls. The aVE of the complete regimen was 96.3% (95%CI: 82.5-99.2). The aVE of the incom-plete pattern was 68.0% (95%CI: 30.0-85.4).Conclusions: The administration of the complete pattern of BNT162b2 vaccine against SARS-CoV-2 is effective for the prevention of cases of COVID-19 in healthcare personnel.(c) 2021 SESPAS. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:484 / 487
页数:4
相关论文
共 15 条
[1]  
[Anonymous], 2021, ESTR DET PREC VIG CO
[2]  
Estrategia de vacunacion frente a COVID-19 en Espana, 2021, ESTR VAC FRENT COVID
[3]  
EUA, 2021, Comirnaty COVID-19 mRNA Vaccine Assesment Report
[4]  
European Centre for Disease Prevention and Control, 2020, GUID NONPH INT RED I
[5]  
European Centre for Disease Prevention and Control, 2021, ENH POSTM MON COVID
[6]   Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021 [J].
Fabiani, Massimo ;
Ramigni, Mauro ;
Gobbetto, Valentina ;
Mateo-Urdiales, Alberto ;
Pezzotti, Patrizio ;
Piovesan, Cinzia .
EUROSURVEILLANCE, 2021, 26 (17) :1-7
[7]   The case test-negative design for studies of the effectiveness of influenza vaccine [J].
Foppa, Ivo M. ;
Haber, Michael ;
Ferdinands, Jill M. ;
Shay, David K. .
VACCINE, 2013, 31 (30) :3104-3109
[8]  
Gras-Valenti P., 2021, REV ESP SALUD P BLIC, V95
[9]   COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study [J].
Hall, Victoria Jane ;
Foulkes, Sarah ;
Saei, Ayoub ;
Andrews, Nick ;
Oguti, Blanche ;
Charlett, Andre ;
Wellington, Edgar ;
Stowe, Julia ;
Gillson, Natalie ;
Atti, Ana ;
Islam, Jasmin ;
Karagiannis, Ioannis ;
Munro, Katie ;
Khawam, Jameel ;
Chand, Meera A. ;
Brown, Colin S. ;
Ramsay, Mary ;
Lopez-Bernal, Jamie ;
Hopkins, Susan .
LANCET, 2021, 397 (10286) :1725-1735
[10]   Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021 [J].
Martinez-Baz, Ivan ;
Miqueleiz, Ana ;
Casado, Itziar ;
Navascues, Ana ;
Trobajo-Sanmartin, Camino ;
Burgui, Cristina ;
Guevara, Marcela ;
Ezpeleta, Carmen ;
Castilla, Jesus .
EUROSURVEILLANCE, 2021, 26 (21)